Who owns Tempest Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Tempest Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Tempest Therapeutics stock

Who bought or sold Tempest Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Sabby Management 179k $513k 100% Dec 2025
 View chart
Vanguard Group 163k $466k 0% Dec 2025
 View chart
Geode Capital Management 44k $127k 8% Dec 2025
 View chart
BlackRock 39k $112k 0% Dec 2025
 View chart
FMR 33k $332k 0% Sep 2025
 View chart
UBS Group 18k $50k 54% Dec 2025
 View chart
Northern Trust 14k $40k 100% Dec 2025
 View chart
Dimensional Fund Advisors 11k $33k 100% Dec 2025
 View chart
DRW Holdings 10k $30k -45% Dec 2025
 View chart
Advisor Group Holdings 1.6k $4.6k -3% Dec 2025
 View chart
Tower Research Capital 1.3k $3.8k 100% Dec 2025
 View chart
Atlantic Trust 1.1k $3.1k 135% Dec 2025
 View chart
Federation des caisses Desjardins du Quebec 292.00 $838.010800 0% Dec 2025
 View chart
Jones Financial Companies, L.L 239.00 $686.001700 100% Dec 2025
 View chart
SBI Securities 56.00 $161.000000 0% Dec 2025
 View chart
Parallel Advisors 18.00 $52.000200 0% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 3.00 $9.000000 0% Dec 2025
 View chart

Who sold out of Tempest Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Belvedere Trading Sep 2025 30k $312k
Wells Fargo & Company Sep 2025 3.00 $30.999900